One of the most downloaded articles in the journal Personalized Medicine in the past year was a 2017 study by Daryl Pritchard of the Personalized Medicine Coalition (PMC) and co-authors on barriers to integrating personalized medicine into healthcare practice (here).
In a new report funded by AstraZeneca, authors St. Jean et al. take a global perspective and note that in some cases regulatory approval, in other cases reimbursement approval, lag for the diagnostics that drive precision medicine. They suggest some paths forward based on a comparison of countries and stakeholders and emphasize the need for collaboration. See the article here.